Contact: Joan Kureczka
Caption: AIGISRx® Antibacterial Envelope is indicated for holding a pacemaker or implantable cardioverter-defibrillator, thereby creating a stable environment surrounding the device and leads after surgical placement. The biocompatible mesh is coated with antibiotics that elute (dissolve) within a 7 to 10 day period.
Credit: TYRX, Inc.
Usage Restrictions: None
Related news release: Extremely low 90-day cardiac device infection rates with TYRX antibacterial envelope use